Latest Migraine Trust Stories
The Migraine Trust Special Report Legislation potentially flouted amid multimillion days lost each year Three in five workers (60%) who suffer from migraine report their employer has failed to make helpful adjustments, potentially flouting anti-discrimination laws, a charity warns today. Almost half (46.3%) say their workplace treats them unfairly over their absence through sickness, more than one in three (40.5%) feels unsupported by their bosses and colleagues, and three in ten...
MOUNTAIN VIEW, Calif., Oct. 20 /PRNewswire-FirstCall/ --MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that the Company will present nine analyses relating to its LEVADEX(TM) orally inhaled migraine therapy product candidate, including analysis from the FREEDOM-301 Phase 3 trial, at the 2010 European Headache and Migraine Trust International Congress (EHMTIC) in Nice, France. EHMTIC is a biennial congress of the Migraine Trust and the European Headache Federation for...
ROCHESTER, Minn., May 26 /PRNewswire-USNewswire/ -- Patients living with migraine have strong reason for new optimism concerning a positive future. Two review articles and an accompanying editorial, "The Future of Migraine: Beyond Just Another Pill," in the current issue of Mayo Clinic Proceedings, are the basis for an ironic premise. "Migraine is a potentially chronic, progressive disease that substantially affects patients, families, workplaces, and society," according to the editorial...
